Relapsed/Refractory ALL
specificThe return of a disease or a disease becoming unresponsive to the current treatment.
5
Centers
0
Active Trials
$992K
Cancer Funding
Top Centers for Relapsed/Refractory ALL(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | NCI Comprehensive High-Volume Research Center | 74.0 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 56.5 |
| 3 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 56.5 |
| 4 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 56.5 |
| 5 | University of Cincinnati Cancer CenterCincinnati, OH | 56.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →